Spesolimab Shows Promise for Generalized Pustular Psoriasis: Study Dr. Kamal Kant Kohli31 March 2025 9:15 PM ISTPost-hoc analyses of the EFFISAYIL 2 trial revealed improvements in Psoriasis Symptom Scale (PSS), Pain Visual Analog Scale (VAS), and Dermatology...
CDSCO Panel Approves IQVIA RDS's Protocol Amendment Proposal for Spesolimab study Dr. Divya Colin11 Aug 2024 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved IQVIA RDS's...
Boehringer Ingelheim Spevigo injection for generalized pustular psoriasis flares gets CDSCO nod Ruchika Sharma18 May 2024 2:30 PM ISTMumbai: The Central Drugs Standard Control Organisation (CSDCO) in India has approved Boehringer Ingelheim's SPEVIGO (spesolimab) injection, a...
Subcutaneous high-dose spesolimab prevents flares in patients with generalised pustular psoriasis Dr Riya Dave19 Oct 2023 10:15 AM ISTA recent study involving the anti-interleukin-36 receptor monoclonal antibody, Spesolimab, has demonstrated its effectiveness in preventing flares of...
Spesolimab beneficial for prevention of generalized pustular psoriasis flares: Effisayil 2 trial Medha Baranwal6 July 2023 10:00 AM ISTUSA: New late-breaking data from the Effisayil 2 trial revealed an 84% reduction in the risk for generalized pustular psoriasis (GPP) flares with...
Boehringer Ingelheim Spesolimab bags USFDA Breakthrough Therapy Designation for prevention of generalized pustular psoriasis flares Ruchika Sharma3 May 2023 2:30 PM ISTGeneralized pustular psoriasis is a rare and potentially life-threatening chronic neutrophilic skin disease characterized by flares of widespread...
Boehringer Ingelheim gets CDSCO panel nod to market Spesolimab indicated for generalized pustular psoriasis Dr. Divya Colin11 March 2023 6:00 PM ISTNew Delhi: Granting the local clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Boehringer Ingelheim gets European Commission approval for Generalized Pustular Psoriasis flares treatment Spesolimab Ruchika Sharma14 Dec 2022 2:15 PM ISTPeople living with GPP often do not receive a correct or timely diagnosis and may have their symptoms identified as other forms of psoriasis.
IV Spesolimab rapidly effective in treatment of generalized pustular psoriasis: NEJM Dr. Shravani Dali24 Dec 2021 9:00 AM ISTSpesolimab is rapidly effective in the majority of patients within one week of its first intravenous infusion for patients suffering from generalized...
